Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1649]
News [6503]
Articles [99]
Editorials [4]
Conferences [186]
elearning [21]
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Why tumour markers are not recommended as screening tests
Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023
Latest treatments in oesophageal cancer
Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA
Latest treatments in oesophageal cancer ( Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA )
5 Apr 2023
Lung cancer screening and treatment in the Philippines
Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines
Lung cancer screening and treatment in the Philippines ( Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines )
4 Apr 2023
War in Ukraine: The logistical challenges of transferring medical materials
Dr Horia Vulpe, Dr Ruslan Baltaga
War in Ukraine: The logistical challenges of transferring medical materials ( Dr Horia Vulpe, Dr Ruslan Baltaga )
3 Apr 2023
ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance
Prof Heather Payne and Dr Jochen Walz
ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance ( Prof Heather Payne and Dr Jochen Walz )
21 Mar 2023
Participation of Africa to global randomised controlled clinical trials
Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Participation of Africa to global randomised controlled clinical trials ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023
Choosing Wisely campaigns in Africa
Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Choosing Wisely campaigns in Africa ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023
Latest in PARP inhibitors and combination therapies for prostate cancer
Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni...
Latest in PARP inhibitors and combination therapies for prostate cancer ( Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni Efstathiou )
19 Feb 2023
ASCO GU 2023: Latest updates in mRCC
Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor...
ASCO GU 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor Grünwald and Prof Toni Choueiri )
18 Feb 2023
Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC
Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA
Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC ( Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA )
18 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation